Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
04/2000
04/12/2000EP0991793A1 Method for preparing 2-aryl or 2-heterocyclyl chiral propionic acids and their esters
04/12/2000EP0991654A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
04/12/2000EP0991632A1 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
04/12/2000CN1250448A Improved method for producing thiazolidinediones, and new thiazolidinediones
04/12/2000CN1250447A 4-(3-heterocyclyl-1-benzoyl) pyrazoles and their use as herbicides
04/12/2000CN1051308C Oxazolidin-2-one derivatives and medicine containing the same
04/11/2000US6048893 Substituted phenyl compounds with a substituent having A 1,3-benzodioxole ring
04/11/2000US6048885 Fungicides
04/11/2000US6048883 Hypoglycemic agent
04/11/2000CA2082617C Mesomorphic compound, liquid crystal composition, liquid crystal device, display apparatus and display method
04/11/2000CA2007261C Novel tetralin derivatives
04/06/2000WO2000018767A2 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
04/06/2000WO2000018745A1 Oxazolidine derivatives for the treatment and prevention of metabolic bone disorders
04/06/2000WO2000018744A1 Oxazole compounds as prostaglandin e2 agonists or antagonists
04/06/2000WO2000018724A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
04/06/2000WO2000018721A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/06/2000WO1999050205A3 Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
04/06/2000CA2345944A1 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
04/06/2000CA2345474A1 Oxazole compounds as prostaglandin e2 agonists or antagonists
04/05/2000EP0989975A1 Oxazole compounds useful as pge2 agonists and antagonists
04/05/2000EP0989857A1 Novel therapeutic agents that modulate enzymatic processes
04/05/2000EP0785923B1 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
04/05/2000EP0740791A4 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties
04/05/2000EP0740659B1 Phenylthio-oxazoline derivatives
04/05/2000CN1249748A Small molecules useful in treatment of inflamatory disease
04/04/2000US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors
04/04/2000US6045773 Method of detecting cyclooxygenase-2
03/2000
03/30/2000WO2000017175A1 INHIBITORS OF p38
03/30/2000WO2000017152A1 Amine derivatives and skin preparations for external use containing the same
03/30/2000WO2000016766A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
03/30/2000CA2342607A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
03/29/2000EP0988295A1 Heterocyclic substituted piperidines and uses thereof
03/29/2000CN1248973A Oxazolidines as 5-HT2A-antagonists
03/29/2000CN1050841C Indole derivatives and medicinal composition having same
03/28/2000US6043376 Synthesis of alpha-methyl, alpha-substituted amino acids
03/28/2000US6043375 Esterifying protected baccatin iii or deacetylbaccatin iii using an oxazolidinecarboxylic acid, acid halide or anhydride; then replacing protecting groups with hydrogen atoms
03/28/2000US6043266 Microbiocides treating gram-positive bacteria infections and persons with aids
03/28/2000US6043265 Isoxazolyl endothelin antagonists
03/28/2000US6043250 Treating or preventing inflammatory diseases
03/28/2000CA2001003C Olefinically unsaturated compounds, a process for the production of copolymers containing isocyanate groups, the copolymers thus obtained and coating compositions or sealing compounds containing the copolymers
03/23/2000WO2000015620A1 Sulfonyl oxazolones and their use for combating undesirable microorganisms
03/23/2000WO2000015599A1 Process for producing stereoselective nitro compounds
03/23/2000WO2000015230A1 METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN aP2 INHIBITOR AND COMBINATION
03/23/2000WO2000015229A1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000DE19842353A1 New 4-alkyl-5-cyano-3-sulfonyl-oxazolones, used as microbicides, especially fungicides and bactericides, for protecting plants or materials such as wood
03/23/2000CA2344309A1 Method for treating diabetes employing an ap2 inhibitor and combination
03/23/2000CA2344300A1 Method for treating atherosclerosis employing an ap2 inhibitor and combination
03/22/2000EP0987254A1 Novel cyclic diamine compounds and medicine containing the same
03/22/2000EP0986384A1 Inhibitors of protein isoprenyl transferases
03/22/2000CN1248255A 3-heterocyclyl-substituted benzoyl derivatives
03/22/2000CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides
03/21/2000US6040323 Phosphatase inhibitors and methods of use thereof
03/21/2000US6040321 Enzyme inhibitor treating cancer, inflammation and arthritis, neurodegenerative diseases such as alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases
03/21/2000US6040317 Sulfonamide fibrinogen receptor antagonists
03/21/2000US6040126 Open chain a-carbonyl acetanilide yellow dye-forming coupler compound
03/16/2000WO2000014078A1 Process for producing oxazole compound
03/16/2000WO2000014063A1 Therapeutic compounds and methods
03/16/2000WO2000013508A1 Fused-benzene derivatives useful as herbicides
03/16/2000WO2000002881A3 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein
03/16/2000WO1999064047A9 Novel antiviral compounds
03/16/2000WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein
03/16/2000CA2342858A1 Method of screening compounds useful in the treatment of a desease caused by or exacerbated by mpv
03/16/2000CA2342807A1 Production method of oxazole compound
03/15/2000EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
03/15/2000EP0984947A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
03/15/2000EP0984926A2 Building blocks derived from 1,2-aminoalcohols
03/15/2000CN1247530A Acrylonitrile compounds, process for their prodn. and pesticides containing them
03/14/2000US6037498 Chiral syntheses
03/14/2000US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis
03/14/2000US6037395 Conductive resin composition
03/14/2000US6037377 Antiinflammatory agents and antiallergens
03/14/2000US6037359 Isoxazolidinedione derivatives and use thereof
03/14/2000US6037342 Serotonin 5-HT3 receptor partial activator
03/09/2000WO2000012491A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
03/09/2000WO2000012472A2 Process for preparing certain phenyl urea compounds
03/09/2000WO2000012468A1 An improved synthesis of 3-hydroxy-4-amino-benzonitrile
03/09/2000WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000DE19841985A1 New heterocyclic alkanesulfonic and alkane carboxylic acid derivatives are VEGF receptor blockers useful in treatment of e.g. psoriasis, rheumatoid arthritis, stroke, tumors and endometriosis
03/09/2000CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000CA2341718A1 An improved synthesis of 3-hydroxy-4-amino-benzonitrile
03/09/2000CA2341697A1 Process for preparing certain phenyl urea compounds
03/08/2000EP0983999A1 Process for producing amide derivatives and intermediates
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983228A1 Protease inhibitors
03/08/2000CN1050124C Herbicide containing oxazolidinedione derivatives
03/07/2000US6034247 Reactig a unsatursated carboxylated amine with a base; cyclization
03/07/2000US6034246 Anticancer agent
03/07/2000US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists
03/07/2000US6034131 Diphenylethers, process and intermediate products for their preparation, and their use
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/01/2000EP0982302A2 Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them
03/01/2000EP0982301A2 Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them
03/01/2000EP0513387B1 Thiazole derivatives as active oxygen inhibitors
02/2000
02/29/2000US6031133 Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof
02/29/2000US6031110 Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides
02/29/2000US6030964 Binds to retinoic acid receptors and useful for treating psoriasis, autoimmune diseases, tumors, rheumatoid arthritis and for inducing immunosuppression in organ transplantation